Photoacoustic Imaging (PAI) is a technology that combines pulsed laser irradiation with acoustic sensing to provide deep and/or high resolution medical-grade images of tissue structure, pathology and function. Exemplary PAI applications include vascular imaging, cancer detection, and mammography. While PAI is rapidly emerging as a clinically viable approach with wide applicability, there are currently no standard methods to evaluate PAI device performance or image quality. As with many medical imaging modalities, tissue-mimicking phantoms can form the basis of image quality test methods for PAI. While previous phantoms used for PAI systems can adequately mimic the optical or acoustic properties of tissue, none accurately mimic both sets of properties.
The subject invention provides novel poly(vinyl chloride) plastisol (PVCP) formulations that have optical and acoustic properties that can be independently tuned to simulate a range of tissue types. These novel PVCP formulations can be molded into a phantom that mimics the morphology of a specific anatomical body region, part, organ, or a small mammal, as well as its optical and acoustic properties. Alternately, PVCP can be molded into simple geometric forms (e.g. cuboid, cylinder) to produce phantoms with physical properties that are generally representative of biological tissues and can serve as tools for standardized performance testing of PAT devices. When fabricated with well-defined inclusions (e.g., filaments, channels), these phantoms can be used to quantitatively characterize various aspects of PAI system performance (e.g., spatial resolution, signal uniformity, penetration depth, etc.). Key applications of such phantoms include medical device development, design optimization and preclinical validation, system inter-comparison, standardization of multi-institutional clinical trials, manufacturing quality control, constancy testing and routine calibration and repair.
|Potential Commercial Applications||Competitive Advantages|
Thomas Pfefer, William Vogt, Congxian Jia
US Patent 9,920,188 issued 3/20/2018
“Biologically relevant photoacoustic imaging phantoms with tunable optical and acoustic properties.” J Biomed Opt. 2016 Oct;21(10):101405. PMID 26886681.
The U.S. Food and Drug Administration is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize this technology. Parties interested in licensing or collaborative research activities for this technology should contact Whitney Hastings, 240-402-2232, Whitney.Hastings@fda.hhs.gov.
FDA Reference No.: E-2016-003
Whitney Hastings, M.S., Ph.D.
FDA Technology Transfer Program
10903 New Hampshire Ave.
Building WO1, Rm 4214
Silver Spring, MD 20993